Morbidity and Mortality After Liver Surgery for Colorectal Liver Metastases: a Cohort Study in a High-volume Fast-track Programme
Overview
Authors
Affiliations
Background: For colorectal liver metastases, surgery is a high-risk procedure due to perioperative morbidity. The objective was to assess severity of complications after fast-track liver surgery for colorectal liver metastases and their impact on morbidity and mortality.
Methods: All patients were treated according to the same fast-track programme. Complications were graded according to the Clavien-Dindo classification for patients undergoing surgery from 2013 to 2015. Correlation between complications and length of stay was analysed by multivariate linear regression.
Results: 564 patient cases were included of which three patients died within 3 months (0.53%, 95% CI: 0.17-1.64%). Complications were common with Grade ≤ 2 in 167 patients (30%) and ≥ Grade 3a in 93 (16%). Patients without complications had a mean length of stay of 4.1 days, which increased with complications: 1.4 days (95% CI: 1.3-1.5) for Grade 2, 1.7 days (1.5-2.0) for Grade 3a, 2.3 days (1.7-3.0) for Grade 3b, 2.6 days (1.6-4.2) for Grade 4a, and 2.9 days (2.8-3.1) for Grade 4b. Following were associated with increased length of stay: complication severity grade, liver insufficiency, ascites, biliary, cardiopulmonary, and infectious complications.
Conclusions: Complications after liver surgery for colorectal liver metastases, in a fast track setting, were associated with low mortality, and even severe complications only prolonged length of stay to a minor degree.
Klubien J, Knofler L, Larsen P, Nielsen S, Fukumori D, Hillingso J Surg Endosc. 2024; 38(10):5785-5792.
PMID: 39145873 PMC: 11458709. DOI: 10.1007/s00464-024-11125-x.
Emile S, Horesh N, Garoufalia Z, Gefen R, Zhou P, Wexner S Updates Surg. 2024; 76(3):845-853.
PMID: 38568358 PMC: 11130067. DOI: 10.1007/s13304-024-01832-4.
Aparicio-Lopez D, Asencio-Pascual J, Blanco-Fernandez G, Cugat-Andorra E, Gomez-Bravo M, Lopez-Ben S Front Surg. 2023; 10:1223225.
PMID: 37850041 PMC: 10577188. DOI: 10.3389/fsurg.2023.1223225.
Stulpinas R, Zilenaite-Petrulaitiene D, Rasmusson A, Gulla A, Grigonyte A, Strupas K Cancers (Basel). 2023; 15(2).
PMID: 36672317 PMC: 9857181. DOI: 10.3390/cancers15020366.
Jotten L, Steinkraus K, Traub B, Graf S, Mihaljevic A, Kornmann M BJS Open. 2022; 6(6).
PMID: 36537738 PMC: 9764439. DOI: 10.1093/bjsopen/zrac139.